- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07567976
Tai Chi Intervention for Balance Function in Older Adults: Predictive and Modifying Roles of Circadian Age
Effects of Tai Chi on Balance Function in Community-Dwelling Older Adults: A Randomized Controlled Trial Examining the Predictive and Modifying Roles of Circadian Age, With Multi-Omics and Brain Function Assessments
Visão geral do estudo
Status
Intervenção / Tratamento
Descrição detalhada
BACKGROUND AND RATIONALE Falls are a leading cause of injury and disability in older adults, and balance dysfunction is a key modifiable risk factor. Tai Chi, a traditional Chinese mind-body exercise, has been shown to improve balance, reduce fall risk, and benefit cognitive health in older populations. However, individual variability in response to Tai Chi remains poorly understood, and the biological mechanisms underlying its benefits are incompletely characterized.
Circadian rhythm disruption has emerged as a hallmark of biological aging. The investigators have developed and validated a circadian age (CircAge) assessment system based on the UK Biobank cohort (N>90,000), which independently predicts mortality risk. Whether individuals with accelerated circadian aging benefit more from Tai Chi intervention is unknown. This trial addresses this gap by integrating circadian age assessment with multi-modal outcome evaluations.
OBJECTIVES The primary objective is to evaluate the effect of a 12-week Tai Chi intervention on balance function in community-dwelling older adults. Secondary objectives are to assess effects on physical function, psychological health, cognitive function, and sleep quality. Exploratory objectives are to examine the predictive and modifying roles of baseline circadian age acceleration on intervention outcomes.
STUDY DESIGN This is a two-arm parallel, single-blind (assessor-blinded) randomized controlled trial. Ninety community-dwelling older adults are randomly allocated 1:1 to a Tai Chi group or a health education control group. Randomization is computer-generated using variable block sizes, stratified by sex and baseline Berg Balance Scale score (≤45 vs >45). Allocation concealment is maintained via sequentially numbered opaque sealed envelopes. Outcome assessors are blinded to group allocation. After the 12-week intervention, the control group is offered free Tai Chi classes to ensure ethical equipoise.
ASSESSMENT SCHEDULE Wrist-worn accelerometer (ActiGraph) recordings are collected at baseline over 7 consecutive days for circadian age computation. All baseline accelerometer recordings are completed prior to randomization. Full outcome assessments are conducted at baseline (week 0) and at the end of intervention (week 12). A streamlined midpoint assessment (week 6) includes only the Berg Balance Scale and Timed Up and Go test. Fasting blood samples for routine clinical chemistry are collected at week 0 and week 12.
STATISTICAL ANALYSIS A sample size of 90 (45 per group) provides >80% power to detect a standardized effect size of d=0.50 in Berg Balance Scale change at week 12, assuming α=0.05 (two-sided) and 20% attrition. The primary analysis follows the intention-to-treat principle using linear mixed-effects models adjusted for baseline score, age, sex, and circadian age acceleration, with class as a random effect for the Tai Chi group. Exploratory analyses include circadian age × group interaction terms.
LONG-TERM FOLLOW-UP After the 12-week intervention, participants are invited to enter a long-term health database with periodic follow-ups tracking balance function, fall events, and overall health status.
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Zhide Liang, MS
- Número de telefone: 0853-65597656
- E-mail: p2516238@mpu.edu.mo
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
Descrição
Inclusion Criteria:
- Aged 55 years or older
- Community-dwelling
- Able to walk independently (assistive devices such as canes are permitted)
- Berg Balance Scale (BBS) score ≤52 at screening
- Able to understand and follow verbal instructions
- Willing to wear a wrist accelerometer continuously for 7 days at baseline
- Willing to accept random group assignment
- Willing to undergo blood collection during the study
- Provides written informed consent
Exclusion Criteria:
- Regular Tai Chi or yoga practice (more than once per week) within the past 6 months
- Severe cognitive impairment (Montreal Cognitive Assessment [MoCA] score <20 at screening, or previously diagnosed dementia)
- Unstable cardiovascular disease (myocardial infarction, stroke, or hospitalization within the past 3 months)
- Severe musculoskeletal disease that limits exercise participation
- Neurological diseases affecting balance (e.g., Parkinson's disease, severe peripheral neuropathy)
- Currently participating in another exercise intervention study
- Planned surgery or extended absence during the study period
- Contraindications to functional near-infrared spectroscopy (fNIRS) examination (e.g., scalp injury, metallic implants in the head region)
- Severe psychiatric illness (e.g., schizophrenia, bipolar disorder)
- Considered unable to safely participate in moderate-intensity physical activity as judged by the study physician or attending healthcare provider
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Prevenção
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Tai Chi Group
Participants in this group receive instruction in Yang-style 24-form Tai Chi from a nationally certified master coach.
Tai Chi classes are offered five days per week, and participants are required to attend at least three sessions per week.
Each session lasts 60 minutes, including warm-up, Tai Chi practice, cool-down, and Q&A.
The intervention duration is 12 weeks.
Class size is limited to 10-15 participants to ensure individualized guidance.
|
Yang-style 24-form Tai Chi taught by a nationally certified master coach.
Classes are offered five days per week, with participants required to attend at least three sessions per week, for a total of 12 weeks (target: ≥36 sessions).
Each 60-minute session includes a 10-minute warm-up, 35 minutes of Tai Chi practice, 10 minutes of cool-down (including standing meditation and breathing exercises), and 5 minutes for questions and home practice reminders.
Class size is limited to 10-15 participants.
|
|
Comparador Ativo: Health Education Control Group
Participants in this group attend health education seminars led by professional medical and health management staff.
Seminar topics include nutrition, chronic disease management, fall prevention, and safe medication use.
The intervention duration is 12 weeks.
After the intervention ends, this group is offered free Tai Chi classes to ensure ethical equipoise.
|
Structured health education program delivered by professional medical and health management staff.
Seminars cover topics including nutrition and dietary guidance, chronic disease management (hypertension, diabetes), fall prevention strategies, safe medication use, and general health literacy for older adults.
The intervention runs for 12 weeks.
Participants receive the same health screening, evaluation, and feedback benefits as the Tai Chi group.
Free Tai Chi classes are offered to this group after the intervention period ends.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in Berg Balance Scale (BBS) Score
Prazo: Change from baseline to end of intervention, up to 12 weeks
|
The Berg Balance Scale (BBS) is a 14-item performance-based measure of static and dynamic balance.
Each item is scored 0-4 based on the participant's ability to perform tasks such as sitting to standing, transfers, standing unsupported with eyes closed, turning, and single-leg stance.
Total scores range from 0 to 56, with higher scores indicating better balance function.
Lower scores are associated with increased fall risk.
|
Change from baseline to end of intervention, up to 12 weeks
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in Single-Leg Eye-Closed Standing Time
Prazo: Change from baseline to end of intervention, up to 12 weeks
|
Static balance is assessed by measuring the time (in seconds) participants can maintain single-leg standing with eyes closed.
Both legs are tested.
Longer times indicate better static balance and proprioception.
|
Change from baseline to end of intervention, up to 12 weeks
|
|
Change in Vertical Jump Height
Prazo: Change from baseline to end of intervention, up to 12 weeks
|
Vertical jump test measures lower-extremity power and neuromuscular function.
Participants perform three consecutive jumps, and the maximum jump height (in centimeters) is recorded.
|
Change from baseline to end of intervention, up to 12 weeks
|
|
Change in Reaction Time
Prazo: Change from baseline to end of intervention, up to 12 weeks
|
Reaction time test measures central nervous system processing speed using a portable reaction time device.
Faster reaction times are associated with lower fall risk and better cognitive processing.
|
Change from baseline to end of intervention, up to 12 weeks
|
|
Change in Activities-Specific Balance Confidence (ABC) Scale
Prazo: Change from baseline to end of intervention, up to 12 weeks
|
The ABC Scale is a 16-item self-report measure of balance confidence during specific activities (e.g., walking, reaching, climbing stairs).
Each item is rated 0-100%, with higher scores indicating greater balance confidence.
|
Change from baseline to end of intervention, up to 12 weeks
|
|
Change in Geriatric Depression Scale (GDS-15) Score
Prazo: Change from baseline to end of intervention, up to 12 weeks
|
The 15-item Geriatric Depression Scale (GDS-15) screens for depressive symptoms in older adults.
Total scores range from 0 to 15, with scores ≥5 suggesting depression.
|
Change from baseline to end of intervention, up to 12 weeks
|
|
Change in Generalized Anxiety Disorder Scale (GAD-7) Score
Prazo: Change from baseline to end of intervention, up to 12 weeks
|
The 7-item Generalized Anxiety Disorder Scale (GAD-7) measures anxiety severity.
Total scores range from 0 to 21, with scores ≥10 indicating moderate-to-severe anxiety.
|
Change from baseline to end of intervention, up to 12 weeks
|
|
Change in Montreal Cognitive Assessment (MoCA) Score
Prazo: Change from baseline to end of intervention, up to 12 weeks
|
The Montreal Cognitive Assessment (MoCA) is a 30-point cognitive screening tool covering visuospatial/executive function, naming, memory, attention, language, abstraction, delayed recall, and orientation.
Scores ≥26 are considered normal cognitive function.
|
Change from baseline to end of intervention, up to 12 weeks
|
|
Change in Pittsburgh Sleep Quality Index (PSQI) Score
Prazo: Change from baseline to end of intervention, up to 12 weeks
|
The Pittsburgh Sleep Quality Index (PSQI) is a 19-item self-report questionnaire assessing sleep quality over the past month.
Total scores range from 0 to 21, with scores >5 indicating poor sleep quality.
|
Change from baseline to end of intervention, up to 12 weeks
|
|
Change in Timed Up and Go (TUG) Test
Prazo: Change from baseline to end of intervention, up to 12 weeks
|
Functional mobility and dynamic balance test.
Participants stand from an armed chair, walk 3 meters, turn, walk back, and sit down.
Time to complete the task is recorded in seconds.
Longer times indicate poorer mobility and higher fall risk.
|
Change from baseline to end of intervention, up to 12 weeks
|
|
Change in Grip Strength
Prazo: Change from baseline to end of intervention, up to 12 weeks
|
Maximum grip strength measured using a handheld dynamometer, in kilograms. Three trials per hand; maximum value recorded. Higher values indicate greater muscle strength. Time Frame: Change from baseline to 12 weeks |
Change from baseline to end of intervention, up to 12 weeks
|
|
Change in Balance Performance Measured by InBody Balance Trainer
Prazo: Change from baseline to end of intervention, up to 12 weeks
|
Static balance assessed via center-of-pressure trajectory recorded by the InBody Balance Trainer during quiet standing, reported in millimeters.
Shorter path length indicates better postural control.
|
Change from baseline to end of intervention, up to 12 weeks
|
Outras medidas de resultado
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Changes in Blood Metabolomic and Proteomic Profiles
Prazo: Change from baseline to end of intervention, up to 12 weeks
|
Targeted and untargeted metabolomics analysis of serum and plasma samples; proteomics analysis (Olink/SomaScan platform) including inflammatory markers (IL-6, TNF-α, hs-CRP), aging-related proteins (GDF-15), and neurotrophic factors (BDNF).
|
Change from baseline to end of intervention, up to 12 weeks
|
|
Baseline Circadian Age Acceleration (AgeAccel_z)
Prazo: Baseline
|
Circadian age acceleration is derived from 7-day wrist-worn accelerometer (ActiGraph) data processed using the GGIR R package.
AgeAccel_z is the standardized residual of circadian age regressed on chronological age, reported in standard deviation units (z-score).
Positive values indicate accelerated circadian aging relative to chronological age.
|
Baseline
|
|
Changes in Serum Metabolomic Profiles
Prazo: Change from baseline to 12 weeks
|
Targeted and untargeted metabolomics analysis of serum samples.
Differential metabolites between groups are identified using fold change (|FC|>1.2) and false discovery rate (FDR<0.1).
Results are reported as the number of significantly altered metabolites and enriched metabolic pathways.
|
Change from baseline to 12 weeks
|
|
Changes in Serum Proteomic Profiles
Prazo: Change from baseline to 12 weeks
|
Proteomic analysis using Olink or SomaScan platform measuring inflammation-related proteins (IL-6, TNF-α, hs-CRP, IL-1β), aging-related proteins (GDF-15, IGFBP-3), and neurotrophic factors (BDNF, NGF).
Differential proteins between groups are identified using fold change (|FC|>1.5)
and false discovery rate (FDR<0.1).
Results are reported as the number of significantly altered proteins.
|
Change from baseline to 12 weeks
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Diretor de estudo: Baichao Xu, PhD, Hainan Medical College
- Diretor de estudo: Ziheng Ning, PhD, Macao Polytechnic University
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- HainanMC-TaiChi-2026-001
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em Tai Chi Exercise
-
Lidian ChenPeking University Third HospitalAinda não está recrutandoComprometimento cognitivo leve
-
Harvard University Faculty of MedicineBeth Israel Deaconess Medical Center; Brigham and Women's HospitalConcluído
-
Chengdu University of Traditional Chinese MedicineAinda não está recrutandoQualidade de vida | Diálise; Complicações | Medicina chinesa
-
National Institute on Aging (NIA)National Center for Complementary and Integrative Health (NCCIH)Concluído
-
University Hospital, Clermont-FerrandConcluído
-
Jinan University GuangzhouChaozhou Special Education SchoolConcluídoTranstorno do Espectro do Autismo (TEA)China
-
Taipei Veterans General Hospital, TaiwanNational Science Council, TaiwanConcluído
-
National Center for Complementary and Integrative...Concluído
-
Sheba Medical CenterTel Aviv UniversityRetiradoCancro do ovário | Câncer Peritoneal Primário | Outros cânceres ginecológicosIsrael
-
Northeast Normal UniversityConcluídoPostura da Cabeça para a FrenteChina